leisure time -WSS

leisure time

author：focus 2025-10-01 23:00:48 - browse：66162

Vivistim and Lead — A small Texas company is testing whether pairing vagus nerve stimulation with rehabilitation exercise can restore movement in people who have had a stroke. STAT/MicroTransponder, Inc.

Despite being forced by Hurricane Irma to close its outpatient facilities for several days, the Mayo Clinic in Jacksonville, Fla., is expected to forge ahead this month with a pivotal clinical trial testing whether an electrical implant can rewire the brains of stroke patients so they can use their arms and hands again.

If the patients who receive implants regain significantly more function than those who get only standard rehabilitation, it will show that stroke-damaged brain circuits can be bypassed like shorts in a circuit board, with healthy neurons coaxed into performing the job of those fried by stroke.

Although the results might not be make-or-break for the little 11-year-old Texas company sponsoring the trial (called MicroTransponder, the company’s also testing whether an electrical implant can alleviate tinnitus), there will be more evidence of whether “electroceuticals” — electrical stimuli tailored to treat diseases — work beyond their current use in controlling pain and a few other conditions or will fall short of the buzz surrounding them.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Medical records are filled with copy
Next article： Feng Zhang CRISPR delivery startup lays off quarter of staff

WSS

JPM 2024 Day 3: Biotech Updates from Verve, Roivant, etc

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Videos point to link between seizures and unexplained toddler deaths

How digital tools helped lower hypertension in marginalized patients

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

Doctors' information doesn't help them choose wisely when sick

knowledge

leisure time

focus

The cancer drug shortage isn’t new — and neither are the solutions

GSK Flovent asthma inhalers replaced by authorized generics

Walensky prepares to leave CDC — and Congress — behind

Burning questions for the 2024 JPM Healthcare Conference

After affirmative action ruling, medical educators look to 'holistic review'

Doctors' information doesn't help them choose wisely when sick

Trump demands the U.S. pay no more for drugs than other countries … again

Doctors' information doesn't help them choose wisely when sick

BioMarin wins approval for gene therapy to treat hemophilia A

Key House Republican on health care plans exit from Congress

knowledge

Biogen Alzheimer’s drug launch off to slow start

UCB departs biotech trade group BIO

JPM: CVS says Medicare Advantage patients are impacting profits

What we’ve learned from the Aduhelm mess

PhRMA lawsuit over Medicare drug price negotiation tossed

3 medical device trends to watch in 2024

focus

leisure time

leisure time

Wikipedia